Last update 08 May 2025

TZB-20810

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Target
5-HT1A receptor x HTR3
Action
agonists, antagonists
Mechanism
5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT3 receptor antagonists(5-hydroxytryptamine receptors, ionotropic (HTR3) antagonists)
Therapeutic Areas
Digestive System Disorders
Active Indication-
Inactive Indication
Irritable Bowel Syndrome
Originator Organization
ASKA Pharmaceutical Co., Ltd.ASKA Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
ASKA Pharmaceutical Co., Ltd.ASKA Pharmaceutical Co., Ltd.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with TZB-20810
Login to view more data
100 Translational Medicine associated with TZB-20810
Login to view more data
100 Patents (Medical) associated with TZB-20810
Login to view more data
1
Literatures (Medical) associated with TZB-20810
01 Jan 2009Chemical and Pharmaceutical BulletinQ4 · MEDICINE
Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-HT1A Agonists/5-HT3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)
Q4 · MEDICINE
100 Deals associated with TZB-20810
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Irritable Bowel SyndromePreclinical
Japan
ASKA Pharmaceutical Co., Ltd.ASKA Pharmaceutical Co., Ltd.
01 Jan 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free